Search
for
Sort by
Research 30 of 74
- Effectiveness of short term canrenone treatment in idiopathic hirsutism.
- Liquid chromatography-mass spectrometry for simultaneous determination of spironolactone and canrenone in plasma samples
- Allergic contact dermatitis produced by canrenone
- High-performance liquid chromatography–diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Interaction of spironolactone with rat skin androgen receptor
- Simultaneous determination of seven prohibited substances in cosmetic products by liquid chromatography–tandem mass spectrometry
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid‐induced impaired wound healing
- Mineralocorticoid Receptor Antagonists—A New Sprinkle of Salt and Youth
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Bioavailability of Albumin-Bound Testosterone†
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Androgen antagonists in androgen target tissues
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial
- COVID‐19, androgens, and androgenic alopecia
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Reversal of andro-genetic alopecia in a male. A spironolactone effect?
- Compounding as a Current Therapeutic Option in Dermatology
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Common Causes of Hair Loss and Their Treatment Options
- Rapid determination and quantification of hair-growth compounds in adulterated products by ultra HPLC coupled to quadrupole-orbitrap MS
- Safety of dermatologic medications in pregnancy and lactation